News
📈 Stocks
Olema Shares Slide 15% as AstraZeneca Breast Cancer Trial Fails
(8 days ago)
Olema Pharmaceuticals shares fell 15.1% after AstraZeneca's camizestrant failed a key breast cancer trial, prompting Stifel to cut its price target on…